Dash Debabrata
Thumbay Hospital, Ajman, United Arab Emirates; Beijing Tiantan Hospital, Beijing, China.
Indian Heart J. 2018 Jul-Aug;70(4):548-555. doi: 10.1016/j.ihj.2018.01.021. Epub 2018 Jan 10.
Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) is the last frontier in coronary intervention. PCI of CTO carries multiple advantages, such as significant improvement in symptoms, improvement in abnormal wall motion and left ventricular function and, possibly, increased long-term survival. As of today the procedural success is markedly improved because of technical innovations and is limited to highly experienced operators. To enhance the overall success rate from a worldwide perspective, a thorough understanding of its pathophysiology is critical to further development of newer techniques and technologies. In this review, the author outlines in-depth the evidence that underpins our understanding of CTO pathophysiology and its insight into CTO intervention that incorporates various steps and techniques to cross the lesion.
慢性完全闭塞病变(CTO)的经皮冠状动脉介入治疗(PCI)是冠状动脉介入治疗的最后一个前沿领域。CTO的PCI具有多种优势,如症状显著改善、异常室壁运动和左心室功能改善,以及可能提高长期生存率。截至目前,由于技术创新,手术成功率显著提高,但仅限于经验丰富的术者。从全球角度提高总体成功率,深入了解其病理生理学对于新技术和技术的进一步发展至关重要。在这篇综述中,作者深入概述了支撑我们对CTO病理生理学理解的证据,以及其对CTO介入治疗的见解,该治疗纳入了跨越病变的各种步骤和技术。